Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$698K Buy
24,102
+140
+0.6% +$4.08K 0.08% 98
2024
Q2
$670K Sell
23,962
-117
-0.5% -$3.22K 0.08% 94
2024
Q1
$668K Buy
24,079
+601
+3% +$16.7K 0.09% 63
2023
Q4
$676K Sell
23,478
-65
-0.3% -$1.97K 0.15% 58
2023
Q3
$781K Sell
23,543
-1,228
-5% -$43.4K 0.2% 47
2023
Q2
$909K Sell
24,771
-40
-0.2% -$1.56K 0.23% 46
2023
Q1
$1.01M Buy
24,811
+14,916
+151% +$644K 0.36% 39
2022
Q4
$507K Buy
9,895
+146
+1% +$7K 0.2% 75
2022
Q3
$427K Buy
9,749
+3,952
+68% +$192K 0.22% 60
2022
Q2
$304K Hold
5,797
0.13% 78
2022
Q1
$300K Hold
5,797
0.12% 87
2021
Q4
$342K Hold
5,797
0.14% 82
2021
Q3
$249K Buy
5,797
+14
+0.2% +$620 0.13% 91
2021
Q2
$226K Buy
+5,783
New +$225K 0.13% 100
2021
Q1
Sell
-8,378
Closed -$307K 262
2020
Q4
$307K Buy
+8,378
New +$307K 0.26% 65

Other funds holding PFE

Diversified's PFE Position: Q3 2024 in Review

Diversified increased its Pfizer (PFE) stake by 0.58% in Q3 2024, buying an estimated $4.08K and bringing the position to 24,102 shares worth $698K. The position accounts for 0.08% of the portfolio, ranked #98.

Diversified first reported a position in PFE in Q4 2020 and has held it in 15 quarters since. The position peaked at $1.01M in Q1 2023. 2,911 funds tracked by Wall St. Rank hold PFE as of Q3 2024.

  • Diversified held 24,102 shares of Pfizer worth $698K as of Q3 2024.
  • Diversified bought 140 Pfizer shares in Q3 2024, an estimated $4.08K.
  • Pfizer made up 0.08% of Diversified's portfolio in Q3 2024, its #98 holding.
  • Diversified first reported a position in Pfizer in Q4 2020 and has held it in 15 quarters since.
  • Diversified's Pfizer position peaked at $1.01M in Q1 2023.
  • 2,911 funds tracked by Wall St. Rank held Pfizer as of Q3 2024.

Based on Diversified's 13F filing for Q3 2024, filed 13 Nov 2024.